$VGNT

CLARK KEVIN P sold $5.7M of VGNT

CLARK KEVIN P sold 122,722 shares of Versigent PLC (VGNT) at an average of $46.60 ($45.49–$49.67, $5.72M total) across 6 trades over 2026-09-08 to 2026-09-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · CLARK KEVIN P
Published Sep 10, 2026, 9:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VGNT
Neutral
medium confidence
Mentioned
$VGNT
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VGNTNeutralLow
01

Why it matters

The disclosure updates the insider trading record and may slightly influence sentiment, but it does not introduce new fundamentals (no guidance, contracts, litigation, or operational updates).

02

Market read

Traders may monitor VGNT for follow-on insider activity, but the 10b5-1 framing reduces the likelihood of a strong fundamental repricing.

03

What to watch

The article does not state whether the director’s remaining stake is large relative to typical holdings, nor whether there were concurrent purchases by other insiders or institutions.

Relevance 5/10Novelty 4/10Timing: filed after-hours on 2026-09-10, covering sales dated 2026-09-08 to 2026-09-09

Background

This is an SEC Form 4 insider transaction disclosure for Versigent PLC, reported by director Kevin P. Clark.

Company-level read

Ticker impact

$VGNTNeutralMedium confidence
Context

Versigent PLC director Kevin P. Clark sold about 122,722 shares in open-market trades for roughly $5.72M under a 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a primary Form 4 disclosure, but the trades are explicitly under a pre-arranged 10b5-1 plan and the article provides no new company-specific operational or financial catalyst.

Market effects

No clear sector read-through from a single director 10b5-1 sale without additional company or industry news.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, clustered sales can coincide with periods when insiders expect reduced near-term upside, which can matter for thinly traded small caps.

Key entities

  • Versigent PLC

    Company whose director insider sale is disclosed on Form 4 (VGNT).

  • CLARK KEVIN P

    Director who executed open-market sales under a pre-arranged Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VGNTMedAI 8/10

Versigent Q2 Earnings Call Highlights

Versigent (NYSE:VGNT) reported Q2 net income growth despite $35M incremental interest expense from 1Q 2026 debt financing. Adjusted tax rate rose to 27% from 16% year ago. Sales grew in Asia-Pacific and Americas, fell in EMEA. Copper costs pressured margins, but pass-through recoveries eased. 2026 net sales guidance raised to $9.4B-$9.6B; dividend $0.13 declared.

$VGNTHigh

Versigent PLC (VGNT): Results of Operations and Financial Condition

Versigent PLC (VGNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. PRESS RELEASE Versigent Reports Second Quarter 2026 Results Delivers 11% Net Sales Growth; Raises and Tightens Full-Year 2026 Net Sales Guidance; Initiates Quarterly Dividend SCHAFFHAUSEN, Switzerland, August 4, 2026 – Versigent PLC (NYSE: VGNT), a global leader in the design and